Your institution may have access to this item. Find your institution then sign in to continue.
Title
Announcements.
Abstract
The article offers news briefs related to oncology. The U.S. Food and Drug Administration (FDA) has approved the submission and filed a Biologics License Application of Amgen Inc. for the human monoclonal antibody denosumab. Polymedco Inc. has launched BTA Stat test, a point of care technology for bladder cancer relapse detection. FDA has approved the marketing application for the drug plerixafor, also known as Mozobil.